Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brensocatib in non-cystic fibrosis bronchiectasis
NCT04594369Phase 3Completed
- Sponsor
- Insmed Incorporated
- Start
- Dec 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 36
01
Overview
A Phase 3 trial of brensocatib in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by Insmed Incorporated. Started Dec 2020; status: completed.
02
Drugs
brensocatib
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT04594369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04594369.